Designing Smart Clinical Trials

15 Apr 2024 04:30 pm 05:30 pm
Hall D
DebbieGipson Chairperson National Institutes of Health/NIDDKUnited States
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom

Session Description:
In this session, several aspects important for designing clinical trials will be highlighted.
Learning Objectives:
Understand the importance of sub phenotyping, and the potential of AI tools, and predictive biomarkers in designing clinical trials.

Time Session
04:30 pm
04:45 pm
Patients Subphenotyping: The Example of Diabetic Kidney Disease
John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
04:45 pm
05:00 pm
Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States
05:00 pm
05:15 pm
Targeted Approaches in Clinical Trial Design
HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
05:15 pm
05:30 pm
Q and A